Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Merli

Showing results (21-30 of 156) with videos related to

Pageof 16
Sort By:
Acta Bio-Medica : Atenei Parmensis|June 12, 2020
Hodgkin's lymphoma: post- autologous transplantation consolidation therapyFrancesco Merli, Filippo Ballerini, Barbara Botto, et al.
Hematological Oncology|January 25, 2012
Tumour burden predicts treatment resistance in patients with early unfavourable or advanced stage Hodgkin lymphoma treated with ABVD and radiotherapyPaolo G Gobbi, Emilio Bassi, Manuela Bergonzi, et al.
Annals of Hematology|August 3, 2022
Efficacy and safety of a colostrum- and Aloe vera-based oral care protocol to prevent and treat severe oral mucositis in patients undergoing hematopoietic stem cell transplantation: a single-arm phase II studyMonica Guberti, Stefano Botti, Cristiana Caffarri, et al.
Leukemia & Lymphoma|December 17, 2002
Prospective study of indolent non-follicular non-Hodgkin's lymphoma: validation of Gruppo Italiano per lo studio dei linfomi (GISL) prognostic criteria for watch and wait policyFortunato Morabito, Luca Baldini, Caterina Stelitano, et al.
Cancer|March 31, 2007
Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patientsStefano Sacchi, Samantha Pozzi, Luigi Marcheselli, et al.
Hematological Oncology|November 20, 2020
Gene expression profile unveils diverse biological effect of serum vitamin D in Hodgkin's and diffuse large B-cell lymphomaBenedetta Donati, Angela Ferrari, Alessia Ruffini, et al.
Cancer|May 16, 2007
Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphomaStefano Sacchi, Samantha Pozzi, Raffaella Marcheselli, et al.
Journal of Clinical Medicine|January 25, 2025
Retrospective Analysis of R-COMP Therapy in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Assessing the Impact of Sample Selection BiasChiara Romano, Francesco Branda, Nicola Petrosillo, et al.
International Journal of Radiation Oncology, Biology, Physics|March 12, 2014
Involved-site image-guided intensity modulated versus 3D conformal radiation therapy in early stage supradiaphragmatic Hodgkin lymphomaAndrea Riccardo Filippi, Patrizia Ciammella, Cristina Piva, et al.
Clinical Lymphoma & Myeloma|December 3, 2009
The early- and intermediate-term toxicity to primitive hematopoietic progenitor cells of three chemotherapy regimens for advanced hodgkin lymphomaPaolo G Gobbi, Vittorio Rosti, Francesco Valentino, et al.
Pageof 16

Showing results (21-30 of 156) with videos related to

Sort By:
Pageof 16
Acta Bio-Medica : Atenei Parmensis|June 12, 2020
Hodgkin's lymphoma: post- autologous transplantation consolidation therapyFrancesco Merli, Filippo Ballerini, Barbara Botto, et al.
Hematological Oncology|January 25, 2012
Tumour burden predicts treatment resistance in patients with early unfavourable or advanced stage Hodgkin lymphoma treated with ABVD and radiotherapyPaolo G Gobbi, Emilio Bassi, Manuela Bergonzi, et al.
Annals of Hematology|August 3, 2022
Efficacy and safety of a colostrum- and Aloe vera-based oral care protocol to prevent and treat severe oral mucositis in patients undergoing hematopoietic stem cell transplantation: a single-arm phase II studyMonica Guberti, Stefano Botti, Cristiana Caffarri, et al.
Leukemia & Lymphoma|December 17, 2002
Prospective study of indolent non-follicular non-Hodgkin's lymphoma: validation of Gruppo Italiano per lo studio dei linfomi (GISL) prognostic criteria for watch and wait policyFortunato Morabito, Luca Baldini, Caterina Stelitano, et al.
Cancer|March 31, 2007
Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patientsStefano Sacchi, Samantha Pozzi, Luigi Marcheselli, et al.
Hematological Oncology|November 20, 2020
Gene expression profile unveils diverse biological effect of serum vitamin D in Hodgkin's and diffuse large B-cell lymphomaBenedetta Donati, Angela Ferrari, Alessia Ruffini, et al.
Cancer|May 16, 2007
Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphomaStefano Sacchi, Samantha Pozzi, Raffaella Marcheselli, et al.
Journal of Clinical Medicine|January 25, 2025
Retrospective Analysis of R-COMP Therapy in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Assessing the Impact of Sample Selection BiasChiara Romano, Francesco Branda, Nicola Petrosillo, et al.
International Journal of Radiation Oncology, Biology, Physics|March 12, 2014
Involved-site image-guided intensity modulated versus 3D conformal radiation therapy in early stage supradiaphragmatic Hodgkin lymphomaAndrea Riccardo Filippi, Patrizia Ciammella, Cristina Piva, et al.
Clinical Lymphoma & Myeloma|December 3, 2009
The early- and intermediate-term toxicity to primitive hematopoietic progenitor cells of three chemotherapy regimens for advanced hodgkin lymphomaPaolo G Gobbi, Vittorio Rosti, Francesco Valentino, et al.
Pageof 16